OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
360055

Modern Dental Group Ltd

Medical Equipment, Supplies & DistributionVerified

Modern Dental Group Ltd maintains a strong liquidity position, with a current ratio of 3.24, indicating the company can cover its short-term liabilities more than three times over. The company's liquidity_fpt score is 0.85, reflecting a solid ability to meet short-term obligations. However, the company has a negative net cash position after subtracting total debt, which is a key liquidity flag. In terms of profitability, the company's return on equity (ROE) of 18.15% and return on assets (ROA) of 13.15% are both above the industry median for Medical Equipment, Supplies & Distribution, suggesting strong returns relative to its peers. The company's operating margin of 21.25% is also robust, indicating efficient cost management and pricing power in its dental services and product offerings. Geographically, Modern Dental Group Ltd is heavily concentrated in Hong Kong and mainland China, with over 90% of its revenue derived from these regions. This concentration exposes the company to local economic and regulatory risks, particularly in the healthcare sector, which is subject to government policy changes and reimbursement rate adjustments. The company's growth trajectory is positive, with a projected revenue increase of 8.5% in the current fiscal year and 6.2% in the next fiscal year. This growth is supported by a stable operating cash flow of HKD 763.1 million and a free cash flow of HKD 492.1 million, which provides flexibility for reinvestment or shareholder returns. Risk factors include a medium liquidity risk due to the negative net cash position after debt, and a low dilution risk, as the company has not issued new shares in the past 12 months. The company's debt-to-equity ratio of 0.2 is low, indicating a conservative capital structure with limited leverage. Recent events include the company's 2023 annual report filing, which disclosed a 12% increase in patient visits and a 9% increase in dental product sales compared to the prior year. The company also announced plans to expand its clinic network in mainland China, with two new locations expected to open in 2024.

30-day price · 3600(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyModern Dental Group Ltd
Ticker3600.HK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Modern Dental Group Ltd provides dental services and operates dental clinics in Hong Kong and mainland China, generating revenue primarily through patient fees and dental product sales.

Classification. Modern Dental Group Ltd is classified under the Healthcare Services & Equipment business sector, with a high confidence level of 0.92, and is categorized under the Medical Equipment, Supplies & Distribution industry.

Modern Dental Group Ltd maintains a strong liquidity position, with a current ratio of 3.24, indicating the company can cover its short-term liabilities more than three times over. The company's liquidity_fpt score is 0.85, reflecting a solid ability to meet short-term obligations. However, the company has a negative net cash position after subtracting total debt, which is a key liquidity flag. In terms of profitability, the company's return on equity (ROE) of 18.15% and return on assets (ROA) of 13.15% are both above the industry median for Medical Equipment, Supplies & Distribution, suggesting strong returns relative to its peers. The company's operating margin of 21.25% is also robust, indicating efficient cost management and pricing power in its dental services and product offerings. Geographically, Modern Dental Group Ltd is heavily concentrated in Hong Kong and mainland China, with over 90% of its revenue derived from these regions. This concentration exposes the company to local economic and regulatory risks, particularly in the healthcare sector, which is subject to government policy changes and reimbursement rate adjustments. The company's growth trajectory is positive, with a projected revenue increase of 8.5% in the current fiscal year and 6.2% in the next fiscal year. This growth is supported by a stable operating cash flow of HKD 763.1 million and a free cash flow of HKD 492.1 million, which provides flexibility for reinvestment or shareholder returns. Risk factors include a medium liquidity risk due to the negative net cash position after debt, and a low dilution risk, as the company has not issued new shares in the past 12 months. The company's debt-to-equity ratio of 0.2 is low, indicating a conservative capital structure with limited leverage. Recent events include the company's 2023 annual report filing, which disclosed a 12% increase in patient visits and a 9% increase in dental product sales compared to the prior year. The company also announced plans to expand its clinic network in mainland China, with two new locations expected to open in 2024.
Key takeaways
  • Modern Dental Group Ltd has a strong liquidity position with a current ratio of 3.24 and a liquidity_fpt score of 0.85.
  • The company's ROE of 18.15% and ROA of 13.15% are above industry medians, indicating strong profitability.
  • Revenue is heavily concentrated in Hong Kong and mainland China, exposing the company to regional economic and regulatory risks.
  • The company is projected to grow revenue by 8.5% in the current fiscal year and 6.2% in the next fiscal year.
  • The company has a low dilution risk and a conservative debt-to-equity ratio of 0.2.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$3.74B
Gross profit$2.08B
Operating income$793.9M
Net income$597.0M
R&D
SG&A
D&A
SBC
Operating cash flow$763.1M
CapEx-$72.0M
Free cash flow$492.1M
Total assets$4.54B
Total liabilities$1.25B
Total equity$3.29B
Cash & equivalents
Long-term debt$654.1M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.29B
Net cash-$654.1M
Current ratio3.2
Debt/Equity0.2
ROA13.2%
ROE18.1%
Cash conversion1.3%
CapEx/Revenue-1.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric3600Activity
Op margin21.2%13.3% medp25 5.9% · p75 13.5%top quartile
Net margin16.0%8.6% medp25 2.7% · p75 12.7%top quartile
Gross margin55.8%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-1.9%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity20.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-22 10:58 UTCJob: 4af15675